Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsShortsTraining Academy
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Holly Chitwood, DNP, APRN, FNP-C, AGACNP-BC, CPNP-AC

Advertisement

Articles by Holly Chitwood, DNP, APRN, FNP-C, AGACNP-BC, CPNP-AC

Photo of a nurse showing something on a clipboard to an older patient in bed and another woman, who is next to the patient and holding her hand.

Communication and Education: Improving Patient Outcomes With Bispecific T-Cell Engager Therapies

ByHolly Chitwood, DNP, APRN, FNP-C, AGACNP-BC, CPNP-AC
March 6th 2025
Advertisement

Latest Updated Articles

  • Photo of a nurse showing something on a clipboard to an older patient in bed and another woman, who is next to the patient and holding her hand.
    Communication and Education: Improving Patient Outcomes With Bispecific T-Cell Engager Therapies

    March 6th 2025



Advertisement
Advertisement

Trending on Oncology Nursing News

1

FDA Approves Gedatolisib for HR+/HER2- Advanced Breast Cancer: What Nurses Need to Know

2

FDA Grants Traditional Approval to Selpercatinib for RET-Fusion Solid Tumors

3

FDA Approves Gedatolisib for HR+/HER2- Metastatic Breast Cancer

4

Managing Oncology Care Amidst Rising Wildfire Smoke and Poor Air Quality

5

Optimizing Multiple Myeloma Care: Insights From a Nursing Expert

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us